The molecular examination of pathologically altered cells and tissues at th
e DNA, RNA, and protein level has revolutionised research and diagnostics i
n pathology. However, the inherent heterogeneity of primary tissues with an
admixture of various reactive cell populations can affect the outcome and
interpretation of molecular studies. Recently, microdissection of tissue se
ctions and cytological preparations has been used increasingly for the isol
ation of homogeneous, morphologically identified cell populations, thus ove
rcoming the obstacle of tissue complexity. In conjunction with sensitive an
alytical techniques, such as the polymerase chain reaction, microdissection
allows precise in vivo examination of cell populations, such as carcinoma
in situ or the malignant cells of Hodgkin's disease, which are otherwise in
accessible for conventional molecular studies. However, most microdissectio
n techniques are very time consuming and require a high degree of manual de
xterity, which limits their practical use. Laser capture microdissection (L
CM), a novel technique developed at the National Cancer Institute, is an im
portant advance in terms of speed, ease of use, and versatility of microdis
section. LCM is based on the adherence of visually selected cells to a ther
moplastic membrane, which overlies the dehydrated tissue section and is foc
ally melted by triggering of a low energy infrared laser pulse. The melted
membrane forms a composite with the selected tissue area, which can be remo
ved by simple lifting of the membrane. LCM can be applied to a wide range o
f cell and tissue preparations including paraffin wax embedded material. Th
e use of immunohistochemical stains allows the selection of cells according
to phenotypic and functional characteristics. Depending on the starting ma
terial, DNA, good quality mRNA, and proteins can be extracted successfully
from captured tissue fragments, down to the single cell level. In combinati
on with techniques Like expression library construction, cDNA array hybridi
sation and differential display, LCM will allow the establishment of "genet
ic fingerprints" of specific pathological lesions, especially malignant neo
plasms. In addition to the identification of new diagnostic and prognostic
markers, this approach could help in establishing individualised treatments
tailored to the molecular profile of a tumour. This review provides an ove
rview of the technique of LCM, summarises current applications and new meth
odical approaches, and tries to give a perspective on future developments.
In addition, LCM is compared with other recently developed laser microdisse
ction techniques.